BACKGROUND: The recommended therapy for mild gallstone pancreatitis is cholecystectomy on initial hospitalization. METHODS: Using a 5% national Medicare sample (1996-2005), we evaluated adherence to current recommendations for gallstone pancreatitis (cholecystectomy rates on initial hospitalization and the use of endoscopic retrograde cholangiopancreatography [ERCP]/sphincterotomy). We evaluated predictors of cholecystectomy, gallstone-related readmissions, and 2-year mortality. RESULTS: Adherence to current guidelines was low. Only 57% of 8,452 Medicare beneficiaries presenting to an acute care hospital with a first episode of mild gallstone pancreatitis underwent cholecystectomy on initial hospitalization. Of the patients who did not undergo cholecystectomy, 55% were never evaluated by a surgeon. Likewise, only 28% of patients who did not undergo cholecystectomy had a sphincterotomy. The 2-year readmission rates were higher among patients who did not undergo cholecystectomy (44% vs 4%; P < .0001), and 33% of these patients required cholecystectomy after discharge. In the no cholecystectomy group, ERCP prevented readmissions (hazard ratio, 0.53; 95% confidence interval, 0.47-0.61) and when readmissions occurred they were less likely to be for gallstone pancreatitis in patients who had an ERCP (27.8% vs 53.2%; P < .0001). On multivariate analysis, patients who were older, black, admitted to a nonsurgical service, lived in certain US regions, and had specific comorbidities were less likely to undergo cholecystectomy. CONCLUSION: Adherence to current recommendations for the management of mild gallstone pancreatitis is low in older patients. Our data suggest that >40% of patients who did not undergo cholecystectomy would have benefited from early definitive therapy. Implementation of policies to increase adherence to guidelines would prevent gallstone-related morbidity and mortality in older patients.
BACKGROUND: The recommended therapy for mild gallstone pancreatitis is cholecystectomy on initial hospitalization. METHODS: Using a 5% national Medicare sample (1996-2005), we evaluated adherence to current recommendations for gallstone pancreatitis (cholecystectomy rates on initial hospitalization and the use of endoscopic retrograde cholangiopancreatography [ERCP]/sphincterotomy). We evaluated predictors of cholecystectomy, gallstone-related readmissions, and 2-year mortality. RESULTS: Adherence to current guidelines was low. Only 57% of 8,452 Medicare beneficiaries presenting to an acute care hospital with a first episode of mild gallstone pancreatitis underwent cholecystectomy on initial hospitalization. Of the patients who did not undergo cholecystectomy, 55% were never evaluated by a surgeon. Likewise, only 28% of patients who did not undergo cholecystectomy had a sphincterotomy. The 2-year readmission rates were higher among patients who did not undergo cholecystectomy (44% vs 4%; P < .0001), and 33% of these patients required cholecystectomy after discharge. In the no cholecystectomy group, ERCP prevented readmissions (hazard ratio, 0.53; 95% confidence interval, 0.47-0.61) and when readmissions occurred they were less likely to be for gallstone pancreatitis in patients who had an ERCP (27.8% vs 53.2%; P < .0001). On multivariate analysis, patients who were older, black, admitted to a nonsurgical service, lived in certain US regions, and had specific comorbidities were less likely to undergo cholecystectomy. CONCLUSION: Adherence to current recommendations for the management of mild gallstone pancreatitis is low in older patients. Our data suggest that >40% of patients who did not undergo cholecystectomy would have benefited from early definitive therapy. Implementation of policies to increase adherence to guidelines would prevent gallstone-related morbidity and mortality in older patients.
Authors: Waldemar Uhl; Andrew Warshaw; Clement Imrie; Claudio Bassi; Colin J McKay; Paul G Lankisch; Ross Carter; Eugene Di Magno; Peter A Banks; David C Whitcomb; Christos Dervenis; Charles D Ulrich; Kat Satake; Paula Ghaneh; Werner Hartwig; Jens Werner; Gerry McEntee; John P Neoptolemos; Markus W Büchler Journal: Pancreatology Date: 2002 Impact factor: 3.996
Authors: Kristin M Sheffield; Kenia E Ramos; Clarisse D Djukom; Carlos J Jimenez; William J Mileski; Thomas D Kimbrough; Courtney M Townsend; Taylor S Riall Journal: J Am Coll Surg Date: 2011-03-12 Impact factor: 6.113
Authors: Orhan Alimoglu; Orhan V Ozkan; Mustafa Sahin; Adem Akcakaya; Ramazan Eryilmaz; Gurhan Bas Journal: World J Surg Date: 2003-02-27 Impact factor: 3.352
Authors: Djemila Boerma; Erik A J Rauws; Yolande C A Keulemans; Ignace M C Janssen; Clemens J M Bolwerk; Ron Timmer; Egge J Boerma; Huug Obertop; Kees Huibregtse; Dirk J Gouma Journal: Lancet Date: 2002-09-07 Impact factor: 79.321
Authors: B Joseph Elmunzer; Mohamed Noureldin; Katherine A Morgan; David B Adams; Gregory A Coté; Akbar K Waljee Journal: Am J Gastroenterol Date: 2017-08-15 Impact factor: 10.864
Authors: Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Courtney M Townsend; James S Goodwin; Taylor S Riall Journal: J Am Coll Surg Date: 2012-02-25 Impact factor: 6.113
Authors: Francisco Javier García-Alonso; María de Lucas Gallego; Daniel Bonillo Cambrodón; Alicia Algaba; Gema de la Poza; Rosa María Martín-Mateos; Fernando Bermejo Journal: Dig Dis Sci Date: 2015-01-11 Impact factor: 3.199
Authors: Rafael S Marcari; Renato Micelli Lupinacci; Luis Roberto Nadal; Ronaldo E Rego; Andrea M Coelho; José Francisco de Matos Farah Journal: JSLS Date: 2012 Apr-Jun Impact factor: 2.172